FDA Investigator Lauren N Smith

Lauren N Smith has conducted inspections on 45 sites in 4 countries as of 29 Aug 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
45
Last Inspection Date:
29 Aug 2017
Investigator Role:
FDA Investigator
Redica ID:
100000406
Countries of Inspections:
United States of America, Italy, China, Bulgaria
FDA Investigators that have inspected at least one site in common with Lauren N Smith:
Alan M Barker, Allison A Aldridge, PhD, Allison C Hunter, Allison E Sincek, Amanda M Dunneback, Andrew J Barrowcliff, Andrew J Lang, Angela E Glenn, Anna M Brannen, Ariel Cruz Figueroa, Bailey A Uetrecht, Benjamin D Shuler, Benjamin J Dastoli, Bethany L Subel, Brenda C Hamilton, Brian D Rogers, Brigitte K Hofmann, Bryan J Love, Bryan M Gamble, Bryce A Hammer, Byeongtaek Oh, Cassandra L Abellard, Charisse K Green, Charles C Conn, III, Cherrie A Zachary, Chiaochun J Wang, Christian L Witkovskie, Christina Capacci Daniel, PhD, Christopher T Middendorf, Christopher T Peters, Courtney E Hillier, Craig P Seaborn, Cynthia T Cain, Dale A Nyberg, Darla J Christopher, David P Moorhead, David S Jackson, Dell S Moller, Dennis Cantellops Paite, Diane M Fresch, Diane R Mcdaniel, Djamila Harouaka, Donna F Campbell, Dorathy M Eischen, Douglas T Heitkemper, Dr. Carmelo Rosa, Elisa A Nickum, Elisa A Weckerling, Elizabeth L Loreaux, Elizabeth Ll Edwards, Frederick M Lochner, Heather A Mccauley, Holly J Rapier, Hugh M Mcclure, II, Janet L Bowen, Jason C Klein, Jason D Werne, Javonica F Penn, Jazmine N Still, Jeffrey A Sincek, Jennifer L Gustavus, Jennifer L Jager, Jennifer L Sheehan, Jessica M Wooten, John E Russell, Jr, Jon P Antoniou, Jonathan A Ferguson, Jose Acruz Gonzalez, Joshua P Wireman, Joshua S Hunt, Karen M Kondas, Kathleen D Culver, Kelli L Wilkinson, Kenneth E Felkley, Kevin P Regan, Kimberly A Joseph, Kirk A Dymbrowski, Lauren N Howard, LCDR Chad N Thompson, Lianji Jin, Libia M Lugo, Lindsey M Schwierjohann, Lisa Hornback, Lisa L Flores, Lisa R Hilliar, Logan T Williams, Marianne Allen, Mark E Parmon, Mary B Sheets, Mary E Storch, Matt D Suedkamp, Matthew B Casale, Matthew H Pitts, Michael E Campbell, Michael E Clark, Michael K Larson, Michael P Sheehan, Michele L Obert, Muna Algharibeh, Nadeem I Chaudhry, Nibin Varghese, MS, Nicholas J Presto, Nicholas L Paulin, Paranthaman Senthamaraikannan, Phillip M Pontikos, Pifer, Raquel L Coleman, Richard T Riggie, Richard W Berning, Robbie J Alleman, Roy C Stephens, Samuel A Hamblin, Sandra A Hughes, Shannon A Gregory, Shannon D Fink, Shannon F Underwood, Steven C Madzo, Steven P Eastham, Tamara M Kays, Tarun D Mehta, Ted L Anderson, Teresa K Kastner, Thomas J Arista, Thomas J Prigge, Thomas W Nojek, Thunder N Dunkijacobs, Torrey M Ward, Tracey L Harris, Tyra S Wisecup, Ucheabuchi Cchudi Nwankwor, Vaishali J Patel, Valerie M Steffens, Valerie M Toomey, Veronica Fuentes, MS, Vipulchandra N Dholakia, Wen Ning Chan (Sally), Wendy G Tan, PhD, Ying Zhang, Yvette Mlacour Davis, Zhigang Sun, PhD

Lauren N Smith's Documents

Publish Date Document Type Title
October, 2016 FDA 483 Smithfield BioScience, Inc. - Form 483, 2016-10-27
August, 2016 FDA 483 Apace Packaging LLC - Form 483, 2016-08-04
May, 2017 EIR Adare Pharmaceuticals, Inc. - EIR, 2017-05-19
April, 2017 EIR West-Ward Columbus Inc. - EIR, 2017-04-14
October, 2015 FDA 483 Best Sanitizers, Inc - Form 483, 2015-10-16
June, 2016 EIR Accupack Midwest - EIR, 2016-06-17
September, 2016 FDA 483 Woodbine Products Company - Form 483, 2016-09-06
March, 2016 FDA 483 Patheon Pharmaceuticals Inc. - Form 483, 2016-03-11
February, 2017 FDA 483 Foshan Flying Medical Products Co., Ltd. - Form 483, 2017-02-23
April, 2016 EIR Piramal Pharma Solutions Inc. - EIR, 2016-04-14
September, 2017 EIR Resilience US, Inc. - EIR, 2017-09-07
June, 2016 FDA 483 Accupack Midwest - Form 483, 2016-06-17
October, 2016 EIR Xellia Pharmaceuticals USA LLC - EIR, 2016-10-13
March, 2016 EIR Patheon Pharmaceuticals Inc. - EIR, 2016-03-11
October, 2015 EIR Best Sanitizers, Inc - EIR, 2015-10-16
December, 2016 FDA 483 CIL Isotope Separations, LLC - Form 483, 2016-12-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more